Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Multiple Myeloma 2Lymphoma 2Sarcoma, Alveolar Soft Part 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Nausea and Vomiting 1Philadelphia Chromosome 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Leukemia, B-Cell 1Leukemia 1Hematologic Neoplasms 1Colorectal Neoplasms 1Chondrosarcoma 1Burkitt Lymphoma 1Advanced Solid Tumors 1

Interventions

Ifosfamide 4Sunitinib 3Radiotherapy 3Doxorubicin 3perifosine 2cediranib 2Loperamide 2Filgrastim 2sargramostim 1romidepsin 1pembrolizumab 1pazopanib 1indolepropanol phosphate 1atropine sulfate-diphenoxylate hydrochloride drug combination 1Watchful Waiting 1Warfarin 1Vitamin B 6 1Trabectedin 1Thyroxine 1Radiotherapy, Conformal 1Pyridoxine 1Promethazine 1Prochlorperazine 1Petrolatum 1Observation 1Nivolumab 1Methotrexate 1Mass Spectrometry 1Lorazepam 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Sarcoma, Alveolar Soft Part × Antiemetics × Clear all
NCT00401388 2018-03-07

A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas

AEterna Zentaris

Phase 2 Completed
72 enrolled
Sarcoma

Chondrosarcoma, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡